Cassaday & Co Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.9K Hold
400
– – ﹤0.01% 848
2026
Q2
$31.7K Hold
400
– – ﹤0.01% 703
2026
Q1
$30K Buy
+400
New +$31.6K ﹤0.01% 714

Other funds holding IONS

Cassaday & Co Wealth Management's IONS Position: Q3 2026 in Review

Cassaday & Co Wealth Management held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 400 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Cassaday & Co Wealth Management first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.7K in Q2 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Cassaday & Co Wealth Management held 400 shares of Ionis Pharmaceuticals worth $17.9K as of Q3 2026.
  • Cassaday & Co Wealth Management left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #848 holding.
  • Cassaday & Co Wealth Management first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Cassaday & Co Wealth Management's Ionis Pharmaceuticals position peaked at $31.7K in Q2 2026.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.